Back to Journals » Clinical Ophthalmology » Volume 11

Thin minimal rim width at Bruch’s membrane opening is associated with glaucomatous paracentral visual field loss

Authors Taniguchi EV, Paschalis EI, Li D, Nouri-Mahdavi K, Brauner SC, Greenstein SH, Turalba AV, Wiggs JL, Pasquale LR , Shen LQ 

Received 16 August 2017

Accepted for publication 2 November 2017

Published 8 December 2017 Volume 2017:11 Pages 2157—2167


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Scott Fraser

Elise V Taniguchi,1–3 Eleftherios I Paschalis,1,2 Dejiao Li,1,4 Kouros Nouri-Mahdavi,5 Stacey C Brauner,1 Scott H Greenstein,1 Angela V Turalba,1 Janey L Wiggs,1 Louis R Pasquale,1,6 Lucy Q Shen1

1Department of Ophthalmology, Harvard Medical School, Massachusetts Eye and Ear, Boston, MA, 2Boston Keratoprosthesis Laboratory, Massachusetts Eye and Ear – Schepens Eye Research Institute, Harvard Medical School, Boston, MA, USA; 3Department of Ophthalmology, Universidade Federal de São Paulo, São Paulo, Brazil; 4Department of Ophthalmology, Beijing China-Japan Friendship Hospital, Beijing, People’s Republic of China; 5Department of Ophthalmology, David Geffen School of Medicine and Stein Eye Institute, Los Angeles, CA, USA; 6Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA

Purpose: To compare optic nerve head (ONH) measurements in glaucomatous eyes with paracentral visual field (VF) loss to eyes with peripheral VF loss and controls.
Methods: Open-angle glaucoma (OAG) patients with early paracentral VF loss or isolated peripheral VF loss as well as control subjects underwent ONH imaging with swept-source optical coherence tomography (OCT) and retinal nerve fiber layer (RNFL) imaging with spectral-domain OCT. Minimum rim width at Bruch’s membrane opening (BMO-MRW), lamina cribrosa depth (LCD), and RNFL thickness were compared among the glaucoma and control groups with one-way analysis of variance, Kruskal–Wallis test, and multiple regression analysis.
Results: Twenty-nine eyes from 29 OAG patients (15 early paracentral and 14 isolated peripheral VF loss) and 20 eyes of 20 control subjects were included. The early paracentral and isolated peripheral VF loss groups had similar VF mean deviation (MD) (–5.3±2.7 dB and –3.7±3.0 dB, p=0.15, respectively). Global BMO-MRW was lower in OAG eyes than in controls (193.8±40.0 vs 322.7±62.2 µm, p<0.001), but similar between eyes with early paracentral VF loss and those with isolated peripheral VF loss (187.6±43.4 vs 200.6±36.3 µm; p>0.99). In contrast, the minimal BMO-MRW was lower in eyes with early paracentral loss (69.0±33.6 µm) than in eyes with isolated peripheral loss (107.7±40.2 µm; p=0.03) or control eyes (200.1±40.8 µm; p<0.001). Average and thinnest RNFL thickness did not differ between OAG groups (p=0.61 and 0.19, respectively). Horizontal and vertical LCD did not differ among the OAG groups and controls (p=0.80 and 0.82, respectively). Multivariable linear regression analysis among OAG cases confirmed the association between lower minimal BMO-MRW and early paracentral VF loss (β=–38.3 µm; 95% confidence interval, –69.8 to –6.8 µm; p=0.02) after adjusting for age, gender, MD, and disc size.
Conclusion: Thin minimal BMO-MRW may represent a new structural biomarker associated with early glaucomatous paracentral VF loss.

Keywords: paracentral loss, BMO-MRW, open angle glaucoma, optic nerve damage, swept-source OCT


Glaucoma is a heterogeneous group of disorders characterized by progressive degeneration of retinal ganglion cells and their axons, leading to cupping of the optic nerve head (ONH) with various patterns of visual field (VF) loss.1,2 Functionally, patients with paracentral VF loss can have significant decline in quality of life3 and delayed reaction, while patients with peripheral VF loss increase visual scanning to compensate when driving.4

Clinically, the optic nerve in patients with paracentral VF loss tends to show localized damage, consisting of disc hemorrhage,5 focal narrowing of the rim,6 and acquired optic nerve pits.7 The structural damage associated with paracentral VF loss has been quantified with spectral-domain optical coherence tomography (SD-OCT), which showed localized loss of retinal nerve fiber layer (RNFL) thickness and thinning of macular inner retinal layer compared to eyes with peripheral VF loss.8

Swept-source optical coherence tomography (SS-OCT) is a novel imaging technology, with higher scanning speed, longer wavelength, and improved signal detection than SD-OCT, achieving better simultaneous imaging of both superficial and deep tissue structures.9 These features improve visualization and quantification of localized and subtle glaucomatous changes of the ONH.

Novel quantitative parameters have emerged with improved imaging technologies. The minimum rim width at Bruch’s membrane opening (BMO-MRW), defined as the minimal distance between the termination of BMO and the internal limiting membrane within each radial scan of the ONH,10 provides a surrogate measure for the number of axons entering the ONH.11 Associations between BMO-MRW and VF sensitivity were demonstrated to be stronger than other RNFL and ONH parameters,12 particularly in the later stages of glaucoma.13 Another new parameter is the lamina cribrosa depth (LCD), which describes the posterior displacement of the lamina cribrosa (LC) and is defined as the average distance between a reference line connecting the two termination points of Bruch’s membrane at the ONH and the anterior LC surface.14 Greater LCD was found in glaucoma patients compared to control subjects, and this parameter may vary in different optic disc phenotypes of open-angle glaucoma (OAG).15,16

In this study, we used SS-OCT to measure and compare the prelaminar and laminar ONH tissues in eyes with OAG and control eyes, aiming to identify novel quantitative parameters (biomarkers) associated with glaucomatous paracentral VF loss.

Subjects and methods

This was a prospective, cross-sectional study, approved by the Institutional Review Boards of Massachusetts Eye and Ear (MEE) in accordance with Health Insurance Portability and Accountability Act regulations, and it adhered to the tenets of the Declaration of Helsinki. Each study subject provided written informed consent.

Description of the study sample

Adult patients of European and African descent aged between 30 and 90 years were recruited for this study. Some subjects were part of a prior study by this group comparing SS-OCT and EDI-OCT in measuring quantitative parameters of the ONH.17

Definition of OAG and control groups

Patients with OAG were recruited from the Glaucoma Consultation Service of MEE. These patients had best-corrected visual acuity of at least 20/40, open angles on gonioscopy, a clinical diagnosis of OAG with reproducible VF loss, and corresponding glaucomatous optic nerve damage. Only patients with reliable Humphrey visual field (HVF) tests (fixation loss ≤33%, false-positive rate ≤20% and false-negative rate ≤20%) were included. Patients with previous penetrating glaucoma surgeries (trabeculectomies and glaucoma drainage devices), optic disc torsion more than 15°, or tilt ratio >1.3 (maximum to minimum optic disc diameter) were excluded.18,19

For each OAG patient, the HVF (Swedish Interactive Threshold Algorithm standard, 24-2) dated within 1 year of the imaging date was reviewed independently by two glaucoma specialists (LRP and LQS) and classified into two categories, as described previously20 and outlined briefly here. Each defect comprised of a cluster of three or more contiguous points on the pattern deviation plot with retinal sensitivity depression worse than −5 dB at each point (Figure 1). Early paracentral loss was defined as a VF defect located within the central 10°, either in the superior or in the inferior hemifield, with or without involvement of the peripheral region in the same hemifield. An isolated peripheral loss involved the Bjerrum areas, nasal step, or temporal wedge zones in the superior and/or inferior hemifield, without affecting the central 10°.

Figure 1 Examples of patterns of VF loss on HVFs (Swedish Interactive Threshold Algorithm 24-2) as defined in this study.
Notes: Pattern deviation plots from left eyes are shown. Numeric values are in the top row and probability plots are in the bottom row. Examples of early paracentral loss with superior paracentral region outlined in black (left) and isolated peripheral loss with superior nasal step zone outlined in black (right) are included.
Abbreviations: VF, visual field; HVF, Humphrey visual field.

Control subjects were recruited from the Comprehensive Ophthalmology and Cataract Consultation Service of MEE and were age-matched to OAG cases by decade. The control eyes had best corrected visual acuity of at least 20/40, intraocular pressure (IOP) lower than 22 mmHg, and normal optic nerves (defined as cup-to-disc ratio ≤0.6 in both eyes and cup-to-disc ratio asymmetry <0.2). Patients with family history of glaucoma, any evidence or suspicion of glaucoma (such as abnormality on peripapillary RNFL profile on SD-OCT), ocular hypertension, or significant retinal pathology were excluded. Control subjects did not undergo VF testing.

Image acquisition

The eyes of all subjects were dilated to obtain images with the best quality. A commercially available SS-OCT (Deep Range Imaging OCT-1; Topcon, Tokyo, Japan) was used to image both eyes of all subjects. The device uses a wavelength-sweeping laser, with a center wavelength of 1,050 nm, and acquires 100,000 A-scans/sec with 8 μm axial resolution.21,22 The imaging protocol included a radial B-scan pattern, consisting of 12 sequential sections, and a five-line cross B-scan pattern, consisting of five sequential vertical and five sequential horizontal sections spaced 250 μm apart, all centered on the optic disc. Each image has 32 image frames averaged. At the same visit, peripapillary RNFL thickness was obtained with SD-OCT (Spectralis; Heidelberg Engineering, Heidelberg, Germany). Digital disc photographs (Visucam Pro NM; Carl Zeiss, Meditec, Dublin, CA, USA) were taken in subjects who did not have photos within 12 months of OCT imaging.

Imaging analysis

Two observers (EVT and DL) independently performed measurements of quantitative prelaminar and laminar parameters using customized ImageJ (ImageJ, US National Institutes of Health, Bethesda, MD, USA) plugins. The BMO-MRW was measured within the ONH from radial B-scans. As previously described,17 the internal limiting membrane was automatically delineated, and BMO was manually identified. Subsequently, the minimum distance from BMO to internal limiting membrane was automatically identified and calculated on each side of the 12 radial scans (total of 24 measurements per eye). The global BMO-MRW was the average of 24 measurements; the minimal BMO-MRW (Figure 2) was the lowest value among these 24 measurements of BMO-MRW per eye; the minimal sector BMO-MRW was the lowest value among the 6 sectors, which were obtained by averaging the BMO-MRW measurements of all scans in each sector (Figure S1). In addition, scaled BMO-MRW normalized by disc circumference was calculated according to a published method.23

Figure 2 Quantitative assessment of the ONH with SS-OCT in an eye with early paracentral loss and in an eye with isolated peripheral loss.
Notes: Top row shows an eye with early paracentral loss: disc photograph (left), minimal BMO-MRW =34.8 μm (center left), LCDH =449.1 μm (center), LCDV =478.4 μm (center right), and peripapillary RNFL thickness profile (right). The corresponding HVF is shown in Figure 1 (left). Bottom row shows an eye with isolated peripheral loss: disc photograph (left), minimal BMO-MRW =139.5 μm (center left), LCDH =397.6 μm (center), LCDV =454.9 μm (center right), and peripapillary RNFL thickness profile (right). The corresponding HVF is shown in Figure 1 (right). Arrows in different colors and patterns indicate location and orientation of scans. Minimal BMO-MRW indicated by red circle and red line (center left), LCDH and LCDV as averages of blue lines (center and center right) were measured on images taken with SS-OCT. The red line delineates the anterior lamina cribrosa surface and the green line connects termination points of Bruch’s membrane (center and center right). RNFL thickness was measured with SD-OCT as shown in the RNFL sector maps (right). The average RNFL is the value in the center (G, global). The minimal RNFL was the lowest value in the sectors (NS, superonasal; TS, superotemporal; T, temporal; N, nasal; NI, inferonasal and TI, inferotemporal).
Abbreviations: BMO-MRW, minimum rim width at Bruch’s membrane opening; LCDH, horizontal lamina cribrosa depth; LCDV, vertical lamina cribrosa depth; ONH, optic nerve head; RNFL, retinal nerve fiber layer; HVF, Humphrey visual field; SS-OCT, swept-source optical coherence tomography; SD-OCT, spectral-domain optical coherence tomography.

The LCD was measured in one horizontal and in one vertical scan, which were selected from all scans at 90° and 180° for the best visualization of the anterior LC surface and best centration.17 After the manual delineation of the anterior surface of LC, a reference line connecting BMO was drawn. An ImageJ plugin calculated the perpendicular distance from the reference line to the anterior surface of LC every 100 μm along the reference line (Figure 2) and generated the mean measurement.

Average RNFL thickness and thinnest clock-hour sector of RNFL thickness were extracted from SD-OCT RNFL profile plot.

Statistical analysis

Only one eye per subject was included in the analysis. If both eyes were eligible, the right eye was used for control subjects and eyes with matching VF mean deviation (MD) were used for glaucoma patients. Statistical analysis was performed with the Statistical Package for the Social Sciences (SPSS, v.17, Chicago, IL, USA). The normality of continuous variables was assessed with the Kolmogorov–Smirnov test. Quantitative variables were expressed as mean ± standard deviation (SD) and qualitative variables as percentages. Comparison between groups was performed with one-way analysis of variance for normally distributed variables and Kruskal–Wallis test for nonnormally distributed variables. For quantitative parameters, interobserver agreement was assessed using intraclass correlation coefficient. Statistical significance was assumed at p≤0.05 level, and Bonferroni correction was applied to correct α error for multiple comparisons. Among OAG cases, a multivariate linear regression model was built with minimal BMO-MRW as the dependent variable and the type of VF loss as the main predictor. The model was adjusted for age, gender, VF MD, and BMO circumference.


Forty-nine subjects (29 patients with OAG and 20 controls) were included in this study. The mean ± standard deviation age was 65.7±9.0 years for OAG patients and 66.6±7.1 years for control subjects (p=0.72). In OAG subgroups, patients with early paracentral loss were younger than patients with isolated peripheral loss (61.9±6.3 vs 69.8±9.9 years, p=0.03, Table 1). Ninety-three percent of OAG patients and 95.0% of control subjects were White (p=0.96); no significant difference in ethnicity was found among the OAG subgroups. The mean IOP measured by Goldmann applanation tonometry on the day of imaging was 13.8±2.7 mmHg in OAG eyes, and 14.4±2.2 mmHg in controls (p=0.41); no difference was found among OAG subgroups (p>0.99). The untreated maximum IOP was available in 48 (97.9%) of 49 subjects; it was 19.8±3.4 mmHg in OAG eyes and 15.4±1.8 mmHg in controls (p=0.0001), with no difference between glaucoma subgroups (p=0.84). The HVF MD was −5.3±2.7 dB in the early paracentral loss group and −3.7±3.0 dB in the isolated peripheral loss group (p=0.15).

Table 1 Clinical characteristics among the studied groups
Notes: Values are expressed as mean ± standard deviation unless otherwise specified. *Statistically significant difference, p<0.05. aKnown untreated maximum IOP was available for all control eyes and 28 of 29 glaucoma eyes.?
Abbreviations: IOP, intraocular pressure; VF MD, visual field mean deviation; VF PSD, visual field pattern standard deviation; N/A, not available.

Interobserver agreement was very good for all measured parameters: intraclass correlation coefficient was 0.98, 0.94, 0.93, and 0.96 for global BMO-MRW, minimal BMO-MRW, horizontal LCD, and vertical LCD, respectively.17 All radial images were of adequate quality for BMO-MRW measurements. In 36.2% of the radial images, the LC was not visible and the five-line images were used instead for LCD measurements.

Mean global BMO-MRW was lower in glaucomatous eyes than in control eyes (193.8±40.0 vs 322.7±62.2 μm, p=0.0001) and similar between eyes with early paracentral loss and those with isolated peripheral loss (187.6±43.4 vs 200.6±36.3 μm; p>0.99). Similar findings were obtained with scaled global BMO-MRW (Table 2). The minimal sector BMO-MRW was lowest in eyes with early paracentral loss (109.3±38.2 μm), which differed from the control group (229.1±44.1 μm, p<0.001) but not from the eyes with isolated peripheral loss (139.3±39.5 μm, p=0.17). This was also observed with scaled minimal sector BMO-MRW.

Table 2 Quantitative parameters among the studied group
Notes: Values are expressed as mean ± standard deviation. *Statistically significant difference, p<0.05.?
Abbreviations: SS-OCT, swept source optical coherence tomography; BMO-MRW, minimum rim width at Bruch’s membrane opening; LCDH, horizontal lamina cribrosa depth; LCDV, vertical lamina cribrosa depth; ONH, optic nerve head; SD-OCT, spectral domain optical coherence tomography; RNFLT, retina nerve fiber layer thickness.

The minimal BMO-MRW was 200.1±40.8 μm in control eyes and 87.7±41.2 μm in OAG eyes (p=0.0001). Eyes with early paracentral loss (Figure 2) had significantly lower minimal BMO-MRW than eyes with isolated peripheral loss (69.0±33.6 vs 107.7±40.2 μm, p=0.03). Similarly, low scaled minimal BMO-MRW distinguished eyes with paracentral loss from eyes with isolated peripheral loss (p=0.04) and control eyes (p=0.0001, Table 2). The location of the minimal BMO-MRW was the temporal quadrant in 90% of the control eyes. In eyes with early paracentral loss, the minimal BMO-MRW was located in the inferior quadrant (including inferior-temporal and inferior-nasal) (80%), temporal quadrant (13.3%), or superior-temporal quadrant (6.7%) in that order; 86.7% of all minimal BMO-MRW locations corresponded to the VF defect location. In eyes with isolated peripheral loss, the minimal BMO-MRW was located in the inferior quadrant (57.1%), temporal quadrant (21.4%), superior-temporal quadrant (14.3%), and nasal quadrant (7.1%); 35.7% of all locations corresponded to the hemifield with more severe VF defect (p=0.008 compared to correspondence in early paracentral VF loss).

The mean horizontal LCD was 433.5±94.6 μm in control eyes and 440.8±109.9 μm in OAG eyes (p=0.80), while the mean vertical LCD was 448.8±105.2 μm in controls eyes and 455.7±94.3 μm in OAG eyes (p=0.82). Neither parameter was significantly different among the OAG subgroups (p>0.19 for all, Table 2).

The average RNFL thickness measured with SD-OCT was 96.6±10.4 μm in control eyes and 73.1±12.3 μm in OAG eyes (p=0.0001, Table 2); eyes with early paracentral loss were not significantly different than eyes with isolated peripheral loss (p=0.61); and neither was the thinnest RNFL thickness (p=0.19).

The association between minimal BMO-MRW and paracentral VF loss was further assessed in multiple regression analysis of OAG groups; eyes with isolated peripheral loss served as the reference group. Low minimal BMO-MRW was significantly associated with early paracentral loss (β=−38.3 μm; 95% confidence interval, −69.8 to −6.8 μm; p=0.02, Table 3), after adjusting for age (p=0.86), gender (p=0.08), VF MD (p=0.21), and BMO circumference (p=0.02). A previous report suggest that linear conversion of MD is required to correlate structure with function, as MD is derived from logarithmic scale.11 In our study, linearization of VF MD did not change the outcome of the multiple regression model, and thus the effect of early paracentral loss on minimal BMO-MRW remained significant (β=−36.1 μm; 95% confidence interval, −66.5 to −5.7 μm; p=0.02), after adjusting for age (p=0.74), gender (p=0.07), and linearized VF MD (p=0.17). There is an association between lower minimal BMO-MRW and lower BMO circumference (p=0.01).

Table 3 Multivariate linear regression for the measurement of minimal BMO-MRW
Note: *Statistically significant association, p<0.05.?
Abbreviations: MD, mean deviation; BMO, Bruch’s membrane opening; BMO-MRW, minimum rim width at Bruch’s membrane opening; VF, visual field; CI, confidence interval.


Glaucomatous optic nerve damage manifests in different patterns of VF loss, sometimes involving the central vision early during the course of the disease. In this study, we focused on eyes with early paracentral loss (ie, VF loss within the central 10° with or without peripheral loss in the same hemifield) instead of isolated paracentral loss,5 as glaucomatous paracentral scotomas are usually accompanied by some degrees of peripheral loss in the same hemifield. This was demonstrated by a previous study, which computationally identified VF loss patterns from a database comprised of 13,231 HVFs from the same practice.24 Furthermore, systemic and genetic factors associated with paracentral scotoma have been identified using similar VF criteria.20,25 In this prospective study, with the aid of SS-OCT, we identified prelaminar pathology, in particular thin minimal BMO-MRW to be more common in patients with early paracentral VF loss than in those with isolated peripheral VF loss. Using multivariate regression analysis, we demonstrated that the association between thin minimal BMO-MRW and paracentral loss was independent of VF severity.

Our study supports the use of minimal BMO-MRW as a quantitative parameter in glaucoma evaluation. The parameter BMO-MRW, unlike the clinically used rim area, which is based on clinical disc margin, relies on BMO. It provides a good surrogate for the number of axons entering the ONH,11 and may have better sensitivity and specificity for glaucoma detection than RNFL-based parameters.26,27 In this study, we found that global BMO-MRW was significantly affected in glaucomatous eyes compared to that in controls; this is consistent with the literature.26 Furthermore, OAG eyes with early paracentral VF loss had significantly thinner minimal BMO-MRW compared to eyes with peripheral VF loss, whereas RNFL thickness parameters (thinnest and average), global BMO-MRW (average and scaled), and minimal sector BMO-MRW (average and scaled) were comparable between these two groups. Minimal BMO-MRW may be a unique quantitative ONH biomarker associated with early paracentral VF loss; since the BMO-MRW is measured within the optic nerve, it may be more likely to reflect local ONH changes than peripapillary RNFL thickness, as the latter is measured on average 1.7 mm away from the center of the optic nerve.28 In addition, minimal BMO-MRW represents the focal ON damage corresponding to a discrete area near fixation on the VF, whereas global BMO-MRW and sector BMO-MRW cannot capture the focal thinning (Figure S2).

The multivariate analysis also showed an association between lower minimal BMO-MRW and lower BMO circumference, suggesting that focal thinning of the neuroretinal rim may be more common in smaller discs with glaucoma. Although this observation differs from a report on global BMO-MRW and healthy eyes, where BMO-MRW is lower in eyes with macrodiscs than microdiscs,29 it is consistent with previous characterization of different glaucomatous optic disc phenotypes.30 A disc phenotype associated with paracentral VF loss (focal glaucomatous) was found to have smaller disc size than other phenotypes (senile sclerotic and generalized cup enlargement), which rarely manifest in VF loss near fixation. It is likely that qualitative description of different glaucomatous optic disc appearances can be quantified with novel imaging parameters; minimal BMO-MRW serves as a parameter for focal glaucomatous phenotype.

In contrast to prelaminar pathology, this cross-sectional study of treated OAG patients without incisional surgery versus controls did not find a difference in LCD, among controls or OAG eyes with different VF loss patterns. Previous studies described increased LCD, attributable to posterior displacement, thinning, or remodeling of the LC, as a component of glaucomatous optic neuropathy.14,3133 Our method of measuring LCD was similar to a recent publication using SS-OCT32 but differed from those using EDI-OCT, which averaged LCD obtained from multiple locations of the ONH.14,31 It is also likely that lower or higher IOP and trans-LC pressure gradient may play an important role in LCD.15,34,35 Hence, in this study, where OAG patients on ocular hypotensive treatment and control subjects had similar IOP on the day of imaging, the difference in LCD was not significant. It is also possible that a larger sample size is needed to detect a difference between glaucoma and control subjects.14,32 Additional studies demonstrated thinner LC in patients with glaucoma.36 We were not able to visualize the posterior surface of the LC in a consistent manner and therefore did not include LC thickness measurements.

Our findings suggest that glaucomatous ONH changes associated with early paracentral VF loss may occur primarily as focal lesions in the neuronal tissue, anterior to the LC. There may be localized ischemia affecting the papillomacular bundle of the neuronal tissue, causing severe thinning of the BMO-MRW and paracentral VF loss. This is consistent with previous reports that patients with paracentral loss are more likely to have vascular dysregulation, leading to local ischemia, such as Raynaud’s syndrome.5 In addition, this is supported by clinical examination of the ONH, which shows localized changes such as disc hemorrhage5 or acquired pit7 associated with paracentral VF loss. Additional research is needed to confirm our findings and to optimize the detection strategy for patients at risk for paracentral VF loss.

This study has several limitations. First, it had a relatively small sample size, and the findings need to be confirmed in other studies. Second, the study population was relatively homogeneous, consisting predominantly of white subjects; ONH characteristics might be different in a glaucomatous population of other ethnicities, although a recent study did not find significant difference in BMO-MRW thickness between normal eyes of African descent and European descent.37 Third, the measurement of BMO-MRW was performed manually by experienced observers with the aid of customized software. While this method was found to be reliable and reproducible in our previous study,17 existing automated segmentation software for BMO-MRW may require manual correction and further refinement. Finally, given the cross-sectional design of this study, a cause and effect relation could not be established.


Our study showed that glaucomatous optic nerve damage can manifest in the prelaminar tissue as focal thinning of BMO-MRW; thin minimal BMO-MRW may represent a new structural biomarker associated with glaucomatous paracentral scotoma.


The authors thank Dr John Miller, Dr Neha Sangal, and Marissa Shoji for data collection; Taibo Li and Haobing Wang for assisting with measurements of optic nerve head parameters; Dr Tobias Elze for calculating linearized visual field mean deviation values; Massachusetts Eye and Ear Fluorescein Laboratory Photographers for performing the imaging protocols described in this paper; and Massachusetts Eye and Ear study coordinators.

This work was supported by the Harvard Glaucoma Center of Excellence and the Miller Research Funds at the Massachusetts Eye and Ear. Some of the results of this paper were presented at the Association for Research in Vision and Ophthalmology as a conference talk with interim findings. The poster’s abstract was published in “ARVO Annual Meeting Abstract” in Invest Ophthalmol Vis Sci:


Louis R Pasquale is supported by a Harvard Medical School Distinguished Scholar Award. Lucy Q Shen is supported by the Eleanor and Miles Shore Fellowship, Harvard Medical School. The authors report no other conflicts of interest in this work.



Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet. 2004;363(9422):1711–1720.


Keltner JL, Johnson CA, Cello KE, et al. Classification of visual field abnormalities in the ocular hypertension treatment study. Arch Ophthalmol. 2003;121(5):643–650.


Abe RY, Diniz-Filho A, Costa VP, Gracitelli CP, Baig S, Medeiros FA. The impact of location of progressive visual field loss on longitudinal changes in quality of life of patients with glaucoma. Ophthalmology. 2016;123(3):552–557.


Coeckelbergh TR, Brouwer WH, Cornelissen FW, Van Wolffelaar P, Kooijman AC. The effect of visual field defects on driving performance: a driving simulator study. Arch Ophthalmol. 2002;120(11):1509–1516.


Park SC, De Moraes CG, Teng CC, Tello C, Liebmann JM, Ritch R. Initial parafoveal versus peripheral scotomas in glaucoma: risk factors and visual field characteristics. Ophthalmology. 2011;118(9):1782–1789.


Jung KI, Park HY, Park CK. Characteristics of optic disc morphology in glaucoma patients with parafoveal scotoma compared to peripheral scotoma. Invest Ophthalmol Vis Sci. 2012;53(8):4813–4820.


Nduaguba C, Ugurlu S, Caprioli J. Acquired pits of the optic nerve in glaucoma: prevalence and associated visual field loss. Acta Ophthalmol Scand. 1998;76(3):273–277.


Lee J, Hangai M, Kimura Y, Takayama K, Kee C, Yoshimura N. Measurement of macular ganglion cell layer and circumpapillary retinal nerve fiber layer to detect paracentral scotoma in early glaucoma. Graefes Arch Clin Exp Ophthalmol. 2013;251(8):2003–2012.


Takayama K, Hangai M, Kimura Y, et al. Three-dimensional imaging of lamina cribrosa defects in glaucoma using swept-source optical coherence tomography. Invest Ophthalmol Vis Sci. 2013;54(7):4798–4807.


Považay B, Hofer B, Hermann B, et al. Minimum distance mapping using three-dimensional optical coherence tomography for glaucoma diagnosis. J Biomed Opt. 2007;12(4):041204.


Gardiner SK, Ren R, Yang H, Fortune B, Burgoyne CF, Demirel S. A method to estimate the amount of neuroretinal rim tissue in glaucoma: comparison with current methods for measuring rim area. Am J Ophthalmol. 2014;157(3):540–549.e1–e2.


Mizumoto K, Gosho M, Zako M. Correlation between optic nerve head structural parameters and glaucomatous visual field indices. Clin Ophthalmol. 2014;8:1203–1208.


Pollet-Villard F, Chiquet C, Romanet JP, Noel C, Aptel F. Structure-function relationships with spectral-domain optical coherence tomography retinal nerve fiber layer and optic nerve head measurementsstructure-function relationships with SD-OCT. Invest Ophthalmol Vis Sci. 2014;55(5):2953–2962.


Park SC, Brumm J, Furlanetto RL, et al. Lamina cribrosa depth in different stages of glaucoma. Invest Ophthalmol Vis Sci. 2015;56(3):2059–2064.


Jung KI, Jung Y, Park KT, Park CK. Factors affecting plastic lamina cribrosa displacement in glaucoma patients. Invest Ophthalmol Vis Sci. 2014;55(12):7709–7715.


Sawada Y, Hangai M, Murata K, Ishikawa M, Yoshitomi T. Lamina cribrosa depth variation measured by spectral-domain optical coherence tomography within and between four glaucomatous optic disc phenotypes. Invest Ophthalmol Vis Sci. 2015;56(10):5777–5784.


Li D, Taniguchi EV, Cai S, et al. Comparison of swept-source and enhanced depth imaging spectral-domain optical coherence tomography in quantitative characterisation of the optic nerve head. Br J Ophthalmol. 2017;101(3):299–304.


Jonas JB, Kling F, Gründler AE. Optic disc shape, corneal astigmatism, and amblyopia. Ophthalmology. 1997;104(11):1934–1937.


Vongphanit J, Mitchell P, Wang JJ. Population prevalence of tilted optic disks and the relationship of this sign to refractive error. Am J Ophthalmol. 2002;133(5):679–685.


Loomis SJ, Kang JH, Weinreb RN, et al. Association of CAV1/CAV2 genomic variants with primary open-angle glaucoma overall and by gender and pattern of visual field loss. Ophthalmology. 2014;121(2):508–516.


Mansouri K, Nuyen B, N Weinreb R. Improved visualization of deep ocular structures in glaucoma using high penetration optical coherence tomography. Expert Rev Med Devices. 2014;10(5):621–628.


Park HY, Shin HY, Park CK. Imaging the posterior segment of the eye using swept-source optical coherence tomography in myopic glaucoma eyes: comparison with enhanced-depth imaging. Am J Ophthalmol. 2014;157(3):550–557.


Patel NB, Sullivan-Mee M, Harwerth RS. The relationship between retinal nerve fiber layer thickness and optic nerve head neuroretinal rim tissue in glaucoma. Invest Ophthalmol Vis Sci. 2014;55(10):6802–6816.


Elze T, Pasquale LR, Shen LQ, Chen TC, Wiggs JL, Bex PJ. Patterns of functional vision loss in glaucoma determined with archetypal analysis. J Royal Soc Interface. 2015;12(103). pii: 20141118.


Kang JH, Loomis SJ, Rosner BA, Wiggs JL, Pasquale LR. Comparison of risk factor profiles for primary open-angle glaucoma subtypes defined by pattern of visual field loss: A prospective study. Invest Ophthalmol Vis Sci. 2015;56(4):2439–2448.


Chauhan BC, O’Leary N, Almobarak FA, et al. Enhanced detection of open-angle glaucoma with an anatomically accurate optical coherence tomography-derived neuroretinal rim parameter. Ophthalmology. 2013;120(3):535–543.


Rebolleda G, Casado A, Oblanca N, Muñoz-Negrete FJ. The new Bruch’s membrane opening – minimum rim width classification improves optical coherence tomography specificity in tilted discs. Clin Ophthalmol. 2016;10:2417–2425.


Schuman JS, Pedut-Kloizman T, Hertzmark E, et al. Reproducibility of nerve fiber layer thickness measurements using optical coherence tomography. Ophthalmology. 1996;103(11):1889–1898.


Enders P, Adler W, Schaub F, et al. Novel Bruch’s membrane opening minimum rim area equalizes disc size dependency and offers high diagnostic power for glaucoma. Invest Ophthalmol Vis Sci. 2016;57(15):6596–6603.


Broadway DC, Nicolela MT, Drance SM. Optic disk appearances in primary open-angle glaucoma. Surv Ophthalmol. 1999;43(Suppl 1):S223–S243.


Lee EJ, Kim TW, Kim M, Kim H. Influence of lamina cribrosa thickness and depth on the rate of progressive retinal nerve fiber layer thinning. Ophthalmology. 2015;122(4):721–729.


Kim DW, Jeoung JW, Kim YW, et al. Prelamina and lamina cribrosa in glaucoma patients with unilateral visual field loss. Invest Ophthalmol Vis Sci. 2016;57(4):1662–1670.


Lee SH, Kim TW, Lee EJ, Girard MJA, Mari JM. Diagnostic power of lamina cribrosa depth and curvature in glaucoma. Invest Ophthalmol Vis Sci. 2017;58(2):755–762.


Quigley H, Arora K, Idrees S, et al. Biomechanical responses of lamina cribrosa to intraocular pressure change assessed by optical coherence tomography in glaucoma eyes. Invest Ophthalmol Vis Sci. 2017;58(5):2566–2577.


Sigal IA, Yang H, Roberts MD, Burgoyne CF, Downs JC. IOP-induced lamina cribrosa displacement and scleral canal expansion: An analysis of factor interactions using parameterized eye-specific models. Invest Ophthalmol Vis Sci. 2011;52(3):1896–1812.


Kwun Y, Han JC, Kee C. Comparison of lamina cribrosa thickness in normal tension glaucoma patients with unilateral visual field defect. Am J Ophthalmol. 2015;159(3):512–518.e1.


Rhodes LA, Huisingh CE, Quinn AE, et al. Comparison of bruch’s membrane opening minimum rim width among those with Normal ocular health by race. Am J Ophthalmol. 2017;174:113–118.

Supplementary materials

Figure S1 Diagram showing scans included in each sector for calculating sector BMO-MRW in a right eye.
Notes: N: 10, 11, 12, 1, 2, 3, 4; SN: 5, 6, 7; ST: 8, 9, 10; T: 11, 12, 1, 2, 3; IT: 4, 5, 6; IN: 7, 8, 9. Similarly, the corresponding scans were used for calculating sector BMO-MRW in left eyes.
Abbreviations: BMO-MRW, minimum rim width at Bruch’s membrane opening; N, nasal; SN, superonasal; ST, superotemporal; T, temporal; IT, inferotemporal; IN, inferonasal.

Figure S2 Example of a left eye with early paracentral loss.
Notes: The corresponding visual field test is shown in Figure 1 left side. The minimal BMO-MRW is 34.8 μm and the minimal sector BMO-MRW, as an average over three adjacent scans, is thicker at 92.4 μm. (A) Minimal BMO-MRW (34.8 μm) is in the inferotemporal sector (red arrow) on scan 6. (B) BMO-MRW in the inferotemporal sector (red arrowheads) is 109.3 μm on scan 5. (C) BMO-MRW in the inferotemporal sector (red arrowheads) is 133.0 μm on scan 4.
Abbreviation: BMO-MRW, minimum rim width at Bruch’s membrane opening.

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.